Todorović, S. RISK OF COVID-19 INFECTION IN PATIENTS WITH MULTIPLE SCLEROSIS TREATED WITH OCRELIZUMAB – A SINGLE CENTER EXPERIENCE. АММ 2023, 62 (3).